Your browser doesn't support javascript.
loading
Molecular regulators of defective placental and cardiovascular development in fetal growth restriction.
Umapathy, Anandita; Clark, Alys; Sehgal, Arvind; Karanam, Vijaya; Rajaraman, Gayathri; Kalionis, Bill; Jones, Helen N; James, Jo; Murthi, Padma.
Affiliation
  • Umapathy A; Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, New Zealand.
  • Clark A; Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, New Zealand.
  • Sehgal A; Auckland Bioengineering Institute, Bioengineering Institute, New Zealand.
  • Karanam V; Department of Paediatrics, Monash University, Melbourne, VIC, Australia and Monash Newborn, Monash Children's Hospital, Melbourne, VIC, Australia.
  • Rajaraman G; Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne and Royal Women's Hospital, Victoria, Australia.
  • Kalionis B; First year college, Victoria University, St Albans, Victoria 3021, Australia.
  • Jones HN; Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne and Royal Women's Hospital, Victoria, Australia.
  • James J; Department of Maternal Fetal Medicine, Pregnancy Research Centre, Royal Women's Hospital, Victoria, Australia.
  • Murthi P; Department of Physiology and Aging, University of Florida College of Medicine, Gainesville, FL, U.S.A.
Clin Sci (Lond) ; 138(13): 761-775, 2024 Jul 03.
Article in En | MEDLINE | ID: mdl-38904187
ABSTRACT
Placental insufficiency is one of the major causes of fetal growth restriction (FGR), a significant pregnancy disorder in which the fetus fails to achieve its full growth potential in utero. As well as the acute consequences of being born too small, affected offspring are at increased risk of cardiovascular disease, diabetes and other chronic diseases in later life. The placenta and heart develop concurrently, therefore placental maldevelopment and function in FGR may have profound effect on the growth and differentiation of many organ systems, including the heart. Hence, understanding the key molecular players that are synergistically linked in the development of the placenta and heart is critical. This review highlights the key growth factors, angiogenic molecules and transcription factors that are common causes of defective placental and cardiovascular development.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Placenta / Fetal Growth Retardation Limits: Animals / Female / Humans / Pregnancy Language: En Journal: Clin Sci (Lond) Year: 2024 Document type: Article Affiliation country: Nueva Zelanda Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Placenta / Fetal Growth Retardation Limits: Animals / Female / Humans / Pregnancy Language: En Journal: Clin Sci (Lond) Year: 2024 Document type: Article Affiliation country: Nueva Zelanda Country of publication: Reino Unido